Evidence map›Paper›PMID 38768950›Full record

ArticleJournal of the American Chemical Society2024

Incorporating Synthetic Accessibility in Drug Design: Predicting Reaction Yields of Suzuki Cross-Couplings by Leveraging AbbVie's 15-Year Parallel Library Data Set.

Priyanka Raghavan, Alexander J Rago, Pritha Verma, Majdi M Hassan, Gashaw M Goshu, Amanda W Dombrowski, Abhishek Pandey, Connor W Coley, Ying Wang

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Carbohydrate Synthesis is Entering the Data-Driven Digital Era.Chemistry (Weinheim an der Bergstrasse, Germany) · 2025
    Review
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Priyanka RaghavanDepartment of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Ave, Cambridge, Massachusetts 02139, United States.ORCID 0009-0002-5949-4570
Alexander J RagoAdvanced Chemistry Technologies Group, AbbVie, Inc., 1 N Waukegan Rd, North Chicago, Illinois 60064, United States.ORCID 0000-0002-9621-1974
Pritha VermaAdvanced Chemistry Technologies Group, AbbVie, Inc., 1 N Waukegan Rd, North Chicago, Illinois 60064, United States.
Majdi M HassanRAIDERS Group, AbbVie, Inc., 1 N Waukegan Rd, North Chicago, Illinois 60064, United States.
Gashaw M GoshuAdvanced Chemistry Technologies Group, AbbVie, Inc., 1 N Waukegan Rd, North Chicago, Illinois 60064, United States.
Amanda W DombrowskiAdvanced Chemistry Technologies Group, AbbVie, Inc., 1 N Waukegan Rd, North Chicago, Illinois 60064, United States.ORCID 0000-0001-9596-263X
Abhishek PandeyRAIDERS Group, AbbVie, Inc., 1 N Waukegan Rd, North Chicago, Illinois 60064, United States.
Connor W ColeyDepartment of Chemical Engineering, Massachusetts Institute of Technology, 77 Massachusetts Ave, Cambridge, Massachusetts 02139, United States.ORCID 0000-0002-8271-8723
Ying WangAdvanced Chemistry Technologies Group, AbbVie, Inc., 1 N Waukegan Rd, North Chicago, Illinois 60064, United States.ORCID 0000-0001-9516-3483

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite the increased use of computational tools to supplement medicinal chemists' expertise and intuition in drug design, predicting synthetic yields in medicinal chemistry endeavors remains an unsolved challenge. Existing design workflows could profoundly benefit from reaction yield prediction, as precious material waste could be reduced, and a greater number of relevant compounds could be delivered to advance the design, make, test, analyze (DMTA) cycle. In this work, we detail the evaluation of AbbVie's medicinal chemistry library data set to build machine learning models for the prediction of Suzuki coupling reaction yields. The combination of density functional theory (DFT)-derived features and Morgan fingerprints was identified to perform better than one-hot encoded baseline modeling, furnishing encouraging results. Overall, we observe modest generalization to unseen reactant structures within the 15-year retrospective library data set. Additionally, we compare predictions made by the model to those made by expert medicinal chemists, finding that the model can often predict both reaction success and reaction yields with greater accuracy. Finally, we demonstrate the application of this approach to suggest structurally and electronically similar building blocks to replace those predicted or observed to be unsuccessful prior to or after synthesis, respectively. The yield prediction model was used to select similar monomers predicted to have higher yields, resulting in greater synthesis efficiency of relevant drug-like molecules.

Indexed as

Drug DesignSmall Molecule LibrariesChemistry, PharmaceuticalDensity Functional TheoryMachine LearningMolecular StructureSmall Molecule Libraries

Identifiers

PMID38768950
PMCPMC11157529

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.